Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-κB

Journal of Medicinal Chemistry

Volumn 47, Issue 24, 2004, Pages 6042-6054

  Siedle, Bettina ^a   García Piñeres, Alfonso J ^a   Murillo, Renato ^b   Schulte Mönting, Jürgen ^a   Castro, Victor ^b   Rüngeler, Peter ^a   Klaas, Christoph A ^a   Da Costa, Fernando B ^c   Kisiel, Wanda ^d   Merfort, Irmgard ^a,e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d POLISH ACADEMY OF SCIENCES   (Poland)

^e NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYBUDLEIN A; BUDLEIN A; CENTRATHERIN; COSTUNOLIDE; CUMAMBRIN A; CUMAMBRIN B; DEHYDROLEUCODIN; DIVERSIFOLIN; ENHYDRINE; EUDESMANOLIDE DERIVATIVE; EUPATORIOPIKRIN; FURANOHELIANGIOLIDE DERIVATIVE; GERMACRANOLIDE DERIVATIVE; GOYAZENSOLIDE; GUAIANOLIDE DERIVATIVE; HELENALIN; HYPOCRETENOLIDE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOGOYAZENSOLIDE; MOLEPHANTIN; MOLEPHANTININ; PARTHENOLIDE; PSEUDOGUAIANOLIDE DERIVATIVE; SCANDENOLIDE; SESQUITERPENE LACTONE; TAMIRIN; TATRIDIN A; THIELEANIN; TIROTUNDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALKYLATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING MOTIF; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MEDICINAL PLANT; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 8644276334     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049937r     Document Type: Article

References (66)

1. Siedle, B.; Gustavsson, L.; Johansson, S.; Murillo, R.; Castro, V.; Bohlin, L.; Merfort, I. The effect of sesquiterpene lactones on the release of human neutrophil elastase. Biochem. Pharmacol. 2003, 65, 897-903.
2. Hall, I. H.; Lee, K. H.; Starnes, C. O.; Sumida, Y.; Wu, R. Y.; Waddell, T. G.; Cochran, J. W.; Gerhart, K. G. Antiinflammatory activity of sesquiterpene lactones and related compounds. J. Pharm. Sci. 1979, 68, 537-541.
3. Hall, I. H.; Starnes, C. O., Jr.; Lee, K. H.; Waddell, T. G. Mode of action of sesquiterpene lactones as antiinflammatory agents. J. Pharm. Sci. 1980, 69, 537-543.
4. Willuhn, G. Arnica flowers: pharmacology, toxicology, and analysis of the sesquiterpene lactones - their main active substances. In Phytomedicines of Europe: Chemistry and Biological Activity; Lawson, L. D., Bauer, R., Eds.; American Chemical Society: Washington, DC, 1998; pp 118-132.
5. Klaas, C. A.; Wagner, G.; Laufer, S.; Sosa, S.; Della Loggia, R.; Bomme, U.; Pahl, H. L.; Merfort, I. Studies on the antiinflammatory activity of phytopharmaceuticals prepared from Arnica flowers. Planta Med. 2002, 68, 385-391.
6. Tornhamre, S.; Schmidt, T. J.; Nasman-Glaser, B.; Ericsson, I.; Lindgren, J. A. Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C(4) synthase in human blood cells. Biochem. Pharmacol. 2001, 62, 903-911.
7. Dirsch, V. M.; Stuppner, H.; Vollmar, A. M. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2. Cancer Res. 2001, 61, 5817-5823.
8. Lyss, G.; Schmidt, T. J.; Merfort, I.; Pahl, H. L. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-κB. Biol. Chem. 1997, 378, 951-961.
9. Rüngeler, P.; Castro, V.; Mora, G.; Goren, N.; Vichnewski, W.; Pahl, H. L.; Merfort, I.; Schmidt, T. J. Inhibition of transcription factor NF-κB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg. Med. Chem. 1999, 7, 2343-2352.
10. Wong, H. R.; Menendez, I. Y. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 1999, 262, 375-380.
11. Bork, P. M.; Schmitz, M. L.; Kuhnt, M.; Escher, C.; Heinrich, M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. FEBS Lett. 1997, 402, 85-90.
12. Klaas, C. A. Phytochemische und pharmakologisch-biologische Untersuchungen von Mikania cordifolia sowie Studien zum molekularen Wirkmechanismus von Sesquiterpenlactonen unter Verwendung des Transkriptionsfaktors NF-AT. Thesis, University Freiburg, 2001.
13. Kuklina, E. M.; Shirshev, S. V. Role of transcription factor NFAT in the immune response. Biochemistry (Moscov) 2001, 66, 467-475.
14. Lee, J. I.; Burckart, G. J. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 1998, 38, 981-993.
15. Baeuerle, P. A.; Henkel, T. Function and activation of NF-B in the immune system. Annu Rev Immunol 1994, 12, 141-179.
16. Pahl, H. L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999, 18, 6853-6866.
17. Barnes, P. J.; Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336, 1066-1071.
18. Lyss, G.; Knorre, A.; Schmidt, T. J.; Pahl, H. L.; Merfort, I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65. J. Biol. Chem. 1998, 273, 33508-33516.
19. Garcia-Pineres, A. J.; Castro, V.; Mora, G.; Schmidt, T. J.; Strunck, E.; Pahl, H. L.; Merfort, I. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J. Biol. Chem. 2001, 276, 39713-39720.
20. Kupchan, S. M.; Fessler, D. C.; Eakin, M. A.; Giacobbe, T. Reaction of alpha methylene lactone tumor inhibitors with model biological nucleophiles. Science 1970, 168, 376-379.
21. Schmidt, T. J. Helenanolide-type sesquiterpene lactones- III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. Bioorg. Med. Chem. 1997, 5, 645-653.
22. Schmidt, T. J. Quantitative structure-cytotoxicity relationships within a series of helenanolide type sesquiterpene lactones. Pharm. Pharmacol. Lett. 1999, 9, 9-13.
23. Fischer, N. H. Sesquiterpenoid lactones. In Methods in plant biochemistry; Charlwood, B. V., Banthorpe, D. V., Eds.; Academic Press limited: London, 1991; pp 187-211.
24. Hall, L. H.; Kier, L. B. The molecular connectivity chi indexes and kappa shape indexes in structure-property modeling. In Reviews in Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; 1992; pp 367-422.
25. Kupchan, S. M.; Eakin, M. A.; Thomas, A. M. Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones. J. Med. Chem. 1971, 14, 1147-1152.
26. Schmidt, T. J.; Heilmann, J. Quantitative structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (Q)-based fractional accessible surface area descriptors (Q_frASAs). Quant. Struct.-Act. Relat. 2002, 21, 276-287.
27. Rodriguez, A. M.; Enriz, R. D.; Santagata, L. N.; Jauregui, E. A.; Pestchanker, M. J.; Giordano, O. S. Structure-cytoprotective activity relationship of simple molecules containing an α,β-unsaturated carbonyl system. J. Med. Chem. 1997, 40, 1827-1834.
28. Enriz, R. D.; Rodriguez, A. M.; Jauregui, E. A.; Pestchanker, M. J.; Giordano, O. S.; Guzman, J. Structure-activity relationship in the cytoprotective effect of helenalin and related compounds. Drug Des. Discovery 1994, 11, 23-38.
29. Marles, R. J.; Pazos-Sanou, L.; Compadre, C. M.; Pezzuto, J. M.; Bloszyk, E.; Arnason, J. T. Sesquiterpene lactones revisited. In Phytochemistry of Medicinal Plants; Arnason, J. T., Ed.; Plenum Press: New York, 1995; pp 333-356.
30. Schmidt, T. J. Toxic activities of sesquiterpene lactones: structural and biochemical aspects. Curr. Org. Chem. 1999, 3, 577-608.
31. Liu, H. X.; Zhang, R. S.; Yao, X. J.; Liu, M. C.; Hu, Z. D.; Fan, B. T. QSAR study of ethyl 2-[(3-methyl-2,5-dioxo(3-pyrrolinyl))-amino]-4- (trifluoromethyl) pyrimidine-5-carboxylate: an inhibitor of AP-1 and NF-kappa B mediated gene expression based on support vector machines. J. Chem. Inf. Comput. Sci. 2003, 43, 1288-1296.
32. Macias, F. A.; Galindo, J. C.; Castellano, D.; Velasco, R. F. Sesquiterpene lactones with potential use as natural herbicide models. 2. guaianolides. J. Agric. Food Chem. 2000, 48, 5288-5296.
33. Willuhn, G. Sesquiterpenlactone, potentielle Leitsubstanzen für die Arzneistofffindung. Dtsch. Apoth. Ztg. 1987, 127, 2511-2517.
34. Hausen, B. M.; Vieluf, I. K. Allergiepflanzen-Pflanzenallergene: Handbuch und Atlas der allergie-induzierenden Wild- und Kulturpflanzen; Ecomed Verlagsgesellschaft, 2001.
35. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
36. Ghose, A. K.; Pritchett, A.; Crippen, G. M. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships 3. J. Comput. Chem. 1988, 9, 80-90.
37. Kier, L. B.; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis; Research Studies Press: Wiley: Letchworth, England, 1986.
38. Rüngeler, P.; Brecht, V.; Tamayo-Castillo, G.; Merfort, I. Germacranolides from Mikania guaco. Phytochemistry 2001, 56, 475-489.
39. Castro, V.; Rüngeler, P.; Murillo, R.; Hernandez, E.; Mora, G.; Pahl, H. L.; Merfort, I. Study of sesquiterpene lactones from Milleria quinqueflora on their anti-inflammatory activity using the transcription factor NF-κB as molecular target. Phytochemistry 2000, 53, 257-263.
40. Goren, N.; Woerdenbag, H. J.; Bozok-Johansson, C. Cytotoxic and antibacterial activities of sesquiterpene lactones isolated from Tanacetum praeteritum subsp. praeteritum. Planta Med. 1996, 62, 419-422.
41. Goren, N.; Tahtasakal, E. Sesquiterpenes of Tanacetum chiliophyllum var. heimerlei. Phytochemistry 1993, 34, 1071-1073.
42. Castro, V.; Murillo, R.; Klaas, C. A.; Meunier, C.; Mora, G.; Pahl, H. L.; Merfort, I. Inhibition of the transcription factor NF-kappa B by sesquiterpene lactones from Podachaenium eminens. Planta Med. 2000, 66, 591-595.
43. Banerjee, S.; Schmeda-Hirschmann, G.; Castro, V.; Schuster, A.; Jakupovic, J.; Bohlmann, F. Further sesquiterpene lactones from Elephantopus mollis and Centratherum punctatum. Planta Med. 1986, 29-32.
44. Kisiel, W. A new germacranolide from Zinnia haageana. Phytochemistry 1978, 17, 1059-1060.
45. Rüngeler, P.; Lyss, G.; Castro, V.; Mora, G.; Pahl, H. L.; Merfort, I. Study of three sesquiterpene lactones from Tithonia diversifolia on their antiinflammatory activity using the transcription factor NF-κB and enzymes of the arachidonic acid pathway as targets. Planta Med. 1998, 64, 588-593.
46. Vichnewski, W.; Leitsaho Filho, H. F.; Nakashima, C.; Lunardello, M. A.; Gutierrez, A. B.; Herz, W. Centratherin and lychnopholide from a new Proteopsis species. Rev. Latinoam. Quim. 1990, 21, 28-29.
47. Lunardello, M. A.; Tomaz, J. C.; Vichnewski, W.; Lopes, J. L. C. Sesquiterpene lactones and flavonoids from Eremanthus mattogrossensis and Eremanthus eriopus. J. Braz. Chem. Soc. 1995, 6, 307-311.
48. Vichnewski, W.; Skrochy, C. A. T. T.; Nasi, A. M.; Calleagri Lopes, J. L.; Herz, W. 15-Hydroxyeremantholide B and derivatives from Eremanthus arboreus. Phytochemistry 1999, 50, 317-320.
49. Vichnewski, W.; Goulart, E. G.; Herz, W. A heliangolide from Calea lantanoides. Phytochemistry 1982, 21, 464-465.
50. Da Costa, F. B.; Vichnewski, W.; Herz, W. Constituents of Viguiera aspillioides and V. robusta. Biochem. Syst. Ecol. 1996, 24, 585-587.
51. Pereira, P. S.; Dias, D. A.; Vichnewski, W.; Nasi, A. M.; Herz, W. Sesquiterpene lactones from Brazilian Tithonia diversifolia. Phytochemistry 1997, 45, 1445-1448.
52. Vichnewski, W.; Lopes, J. L. C.; Dos Santos Filho, D.; Herz, W. 15-Deoxygoiazensolide, a new heliangolide from Vanillomopsis erythropappa. Phytochemistry 1976, 15, 1775-1776.
53. Da Costa, F. B.; Ito, I. Y.; Andre, R. F. G.; Vichnewski, W. Constituents of Viguiera species with antibacterial activity. Fitoterapia 1998, 69, 86-87.
54. Goren, N.; Bozok-Johansson, C.; Jakupovic, J.; Lin, L.-J.; Shieh, H.-L.; Cordell, G. A.; Celik, N. Sesquiterpene lactones with antibacterial activity from Tanacetum densum ssp. sivasicum. Phytochemistry 1992, 31, 101-104.
55. Schorr, K.; Garcia-Pineres, A. J.; Siedle, B.; Merfort, I.; Da Costa, F. B. Guaianolides from Viguiera gardneri inhibit the transcription factor NF-κB. Phytochemistry 2002, 60, 733-740.
56. Kisiel, W. Guaianolides from Picris altissima. Phytochemistry 1992, 31, 328-329.
57. Kisiel, W.; Zielinska, K. Guaianolides from Cichorium intybus and structure revision of Cichorium sesquiterpene lactones. Phytochemistry 2001, 57, 523-527.
58. Kisiel, W. Phytochemical investigation of Vernonia flexuosa Sims. Part II Vernoflexoside and vernoflexin - new sesquiterpenelactones. Pol. J. Pharmacol. Pharm. 1975, 27, 461-467.
59. Willuhn, G.; Kresken, J.; Leven, W. Further helenanolides from the flowers of Arnica chamissonis ssp. foliosa. Planta Medica 1990, 56, 111-115.
60. Merfort, I.; Wendisch, D. Sesquiterpene lactones of Arnica cordifolia. Phytochemistry 1993, 34, 1437.
61. Leven, W. Qualitative und quantitative chromatographische (DC, GC, HPLC) und photometrische Analyse der Sesquiterpenlactone in "Arnikablüten DAB 9" und Untersuchungen zur Sesquiterpenlactonführung in Blüten von Arnica acaulis. Thesis, Universität Düsseldorf, 1988.
62. Zidorn, C.; Dirsch, V. M.; Rüngeler, P.; Sosa, S.; Della Loggia, R.; Merfort, I.; Pahl, H. O.; Vollmar, A. M.; Stuppner, H. Antiinflammatory activities of hypocretenolides from Leontodon hispidus. Planta Med. 1999, 65, 704-708.
63. Kisiel, W. Hypocretenolides from Crepis aurea. Fitoterapia 1994, 65, 381.
64. Goren, N. Sesquiterpene lactones from Tanacetum praeteritum. Phytochemistry 1995, 38, 1261-1264.
65. Siedle, B. Phytochemische und pharmakologisch-biologische Untersuchungen von traditionellen Heilpflanzen aus Costa Rica sowie von Sesquiterpenlactonen und Bindungs- und QSAR-Studien mit der Humanen Neutrophilen Elastase und dem Transkriptionsfaktor NF-κB als molekularen Targets. Thesis, Albert-Ludwigs Universität Freiburg, 2003.
66. Cuenca, M. d. R.; Bardon, A.; Catalan, C. A. N. Sesquiterpene lactones from Mikania micrantha. J. Nat. Prod. 1988, 51, 625-626.